Novel metabolic risk factors for heart failure

Journal of the American College of Cardiology

Volumn 46, Issue 11, 2005, Pages 2054-2060

  Ingelsson, Erik ^a,d   Ärnlöv, Johan ^a   Sundström, Johan ^a   Zethelius, Björn ^a   Vessby, Bengt ^a   Lind, Lars ^b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d Dag Hammarskjölds Väg 10B   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; BETA CAROTENE; PROINSULIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FOLLOW UP; GLUCOSE METABOLISM; HAZARD ASSESSMENT; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; STATISTICAL SIGNIFICANCE; VALVULAR HEART DISEASE; VITAMIN BLOOD LEVEL;

EID: 28244465071     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.07.059     Document Type: Article

References (46)

1. C. Berry, D.R. Murdoch, J.J. McMurray Economics of chronic heart failure Eur J Heart Fail 3 2001 283 291
2. W.B. Kannel, A.J. Belanger Epidemiology of heart failure Am Heart J 121 1991 951 957
3. J.J. McMurray, S. Stewart Epidemiology, aetiology, and prognosis of heart failure Heart 83 2000 596 602
4. D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, K.K. Ho The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562
5. K.K. Ho, J.L. Pinsky, W.B. Kannel, D. Levy The epidemiology of heart failure the Framingham Study J Am Coll Cardiol 22 1993 6A 13A
6. H. Eriksson, K. SvÄrdsudd, B. Larsson Risk factors for heart failure in the general population the study of men born in 1913 Eur Heart J 10 1989 647 656
7. W.B. Kannel, M. Hjortland, W.P. Castelli Role of diabetes in congestive heart failure the Framingham study Am J Cardiol 34 1974 29 34
8. S. Kenchaiah, J.C. Evans, D. Levy Obesity and the risk of heart failure N Engl J Med 347 2002 305 313
9. J.W. Swan, S.D. Anker, C. Walton Insulin resistance in chronic heart failure relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532
10. N. Suskin, R.S. McKelvie, R.J. Burns Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur Heart J 21 2000 1368 1375
11. R.S. Vasan, L.M. Sullivan, R. Roubenoff Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction the Framingham Heart Study Circulation 107 2003 1486 1491
12. M. Cesari, B.W. Penninx, A.B. Newman Inflammatory markers and onset of cardiovascular events results from the Health ABC study Circulation 108 2003 2317 2322
13. A. Serdar, D. Yesilbursa, Z. Serdar, M. Dirican, B. Turel, J. Cordan Relation of functional capacity with the oxidative stress and antioxidants in chronic heart failure Congest Heart Fail 7 2001 309 311
14. A. Wykretowicz, J. Furmaniuk, J. Smielecki The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure Int J Cardiol 94 2004 283 287
15. M.C. Polidori, K. Savino, G. Alunni Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients relationship to disease severity Free Radic Biol Med 32 2002 148 152
16. H. Hedstrand A study of middle-aged men with particular reference to risk factors for cardiovascular disease Ups J Med Sci Suppl 19 1975 1 61
17. ULSAM: Uppsala Longitudinal Study of Adult Men. Available at: http://www.pubcare.uu.se/ULSAM/. Accessed October 8, 2005.
18. W.J. Sobey, S.F. Beer, C.A. Carrington Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins Biochem J 260 1989 535 541
19. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
20. E.T. Skarfors, H.O. Lithell, I. Selinus Risk factors for the development of hypertension a 10-year longitudinal study in middle-aged men J Hypertens 9 1991 217 223
21. D.B. Milne, J. Botnen Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography Clin Chem 32 1986 874 876
22. D.I. Thurnham, J.A. Davies, B.J. Crump, R.D. Situnayake, M. Davis The use of different lipids to express serum tocopherol lipid ratios for the measurement of vitamin E status Ann Clin Biochem 23 1986 514 520
23. R.J. Prineas, R.S. Crow, H. Blackburn The Minnesota Code Manual of Electrocardiographic Findings Standards and Procedures for Measurement and Classification 1982 John Wright Bristol
24. U. Lindblad, L. Rå stam, J. Ranstam, M. Peterson Validity of register data on acute myocardial infarction and acute stroke the Skaraborg Hypertension Project Scand J Soc Med 21 1993 3 9
25. N. Hammar, L. Alfredsson, M. Rosén, C.L. Spetz, T. Kahan, A.S. Ysberg A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden Int J Epidemiol 30 Suppl 1 2001 S30 S34
26. Y.T. Chen, V. Vaccarino, C.S. Williams, J. Butler, L.F. Berkman, H.M. Krumholz Risk factors for heart failure in the elderly a prospective community-based study Am J Med 106 1999 605 612
27. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, D. Levy Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction N Engl J Med 336 1997 1350 1355
28. The Task Force on Heart Failure of the European Society of Cardiology Guidelines for the diagnosis of heart failure Eur Heart J 16 1995 741 751
29. E. Ingelsson, J. Ärnlöv, J. Sundström, L. Lind The validity of a diagnosis of heart failure in a hospital discharge register Eur J Heart Fail 7 2005 787 791
30. M.R. Cowie, A. Mosterd, D.A. Wood The epidemiology of heart failure Eur Heart J 18 1997 208 225
31. T. Melchior, C. Rask-Madsen, C. Torp-Pedersen, P. Hildebrandt, L. Køber, G. Jensen The impact of heart failure on prognosis of diabetic and non-diabetic patients with myocardial infarction a 15-year follow-up study Eur J Heart Fail 3 2001 83 90
32. D.W. Kitzman, J.M. Gardin, J.S. Gottdiener CHS Research Group Importance of heart failure with preserved systolic function in patients <65 years of age. Cardiovascular Health Study Am J Cardiol 87 2001 413 419
33. J.S. Yudkin, M. May, P. Elwood, J.W. Yarnell, R. Greenwood, G. Davey Smith Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin prospective data from the Caerphilly Study Diabetologia 45 2002 327 336
34. B. Zethelius, L. Byberg, C.N. Hales, H. Lithell, C. Berne Proinsulin is an independent predictor of coronary heart disease report from a 27-year follow-up study Circulation 105 2002 2153 2158
35. L. Amato, G. Paolisso, F. Cacciatore The Osservatorio Geriatrico Regione Campania Group Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly Diabetes Metab 23 1997 213 218
36. J.A. Galloway, S.A. Hooper, C.T. Spradlin Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience Diabetes Care 15 1992 666 692
37. J. Ärnlöv, L. Lind, B. Zethelius Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up Am Heart J 142 2001 720 724
38. M.K. Rutter, H. Parise, E.J. Benjamin Impact of glucose intolerance and insulin resistance on cardiac structure and function sex-related differences in the Framingham Heart Study Circulation 107 2003 448 454
39. J. Sundström, L. Lind, N. Nyström Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men Circulation 101 2000 2595 2600
40. A.A. Ariyo, C. Thach, R. Tracy Lp(a) lipoprotein, vascular disease, and mortality in the elderly N Engl J Med 349 2003 2108 2115
41. A.D. Sniderman, C.D. Furberg, A. Keech Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment Lancet 361 2003 777 780
42. B. Lamarche, S. Moorjani, P.J. Lupien Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study Circulation 94 1996 273 278
43. G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, E. Steiner High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study) a prospective study Lancet 358 2001 2026 2033
44. P. Steer, J. Hulthe, J. Millgå rd Endothelial vasodilatory function is predicted by circulating apolipoprotein B and HDL in healthy humans Lipids 37 2002 1135 1140
45. E. Ingelsson, J. Ärnlov, J. Sundström, L. Lind Inflammation, as measured by the erythrocyte sedimentation rate, is an independent predictor for development of heart failure J Am Coll Cardiol 45 2005 1802 1806
46. J. Ärnlöv, L. Lind, J. Sundström, B. Andrén, B. Vessby, H. Lithell Insulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic dysfunction twenty years later Nutr Metab Cardiovasc Dis 15 2005 242 249